,datetime,sentence,positive,negative,neutral,global_sentiment,avg_sentiment
0,2018-06-07 02:32:00,It provides cloud-based software to healthcare companies.,0.0370001345872879,0.004864072427153587,0.9581357836723328,neutral,0.032136060297489166
1,2018-06-07 02:32:00,And it has a track record of strong revenue and earnings growth.,0.9273008108139038,0.013372947461903095,0.05932626500725746,positive,0.9139278531074524
2,2018-06-07 02:32:00,Which company is it?,0.036841344088315964,0.03412410244345665,0.9290345907211304,neutral,0.002717241644859314
3,2018-06-07 02:32:00,Veeva Systems (NYSE: VEEV) is a correct answer.,0.08887236565351486,0.015232425183057785,0.8958951830863953,neutral,0.07363994419574738
4,2018-06-07 02:32:00,So is athenahealth (NASDAQ: ATHN) .,0.03382714092731476,0.00826375000178814,0.9579090476036072,neutral,0.02556339092552662
5,2018-06-07 02:32:00,Veeva Systems has been the better-performing stock so far in 2018.,0.8488256931304932,0.11254075914621353,0.038633592426776886,positive,0.7362849116325378
6,2018-06-07 02:32:00,But which of these two healthcare technology stocks is the better choice for investors now?,0.11862828582525253,0.021635252982378006,0.8597363829612732,neutral,0.09699302911758423
7,2018-06-07 02:32:00,Here's how Veeva and Athenahealth compare.,0.05569996312260628,0.010915543884038925,0.9333844780921936,neutral,0.04478441923856735
8,2018-06-07 02:32:00,"Veeva Systems focuses primarily on providing cloud-based software to the life sciences industry, including customer-relationship management (CRM), content management, and quality management systems.",0.03821069747209549,0.004721133038401604,0.9570682048797607,neutral,0.03348956257104874
9,2018-06-07 02:32:00,What's the main reason to buy Veeva stock?,0.0396517850458622,0.009871557354927063,0.9504767060279846,neutral,0.029780227690935135
10,2018-06-07 02:32:00,I'd say it's the company's excellent growth prospects.,0.8397043943405151,0.011844055727124214,0.1484515219926834,positive,0.8278603553771973
11,2018-06-07 02:32:00,There are three key ways that the company should be able to achieve strong earnings growth in the years to come.,0.7948654890060425,0.011728129349648952,0.1934063881635666,positive,0.7831373810768127
12,2018-06-07 02:32:00,"First, Veeva has plenty of room to grow in gaining new customers in its core life sciences market.",0.899538516998291,0.012124918401241302,0.08833654224872589,positive,0.8874136209487915
13,2018-06-07 02:32:00,"Even though the company claims over 600 customers, including some of the biggest drugmakers in the world, Veeva should be able to continue winning additional customers.",0.9151971340179443,0.016873154789209366,0.0679297000169754,positive,0.8983239531517029
14,2018-06-07 02:32:00,"The company thinks that the total addressable market for its two primary revenue-generating products, Commercial Cloud and Veeva Vault, is more than 10 times greater than its current sales.",0.7699306011199951,0.014292443171143532,0.21577700972557068,positive,0.7556381821632385
15,2018-06-07 02:32:00,"Second, Veeva should be able to get existing customers to adopt more of its applications.",0.8994491100311279,0.012838918715715408,0.08771192282438278,positive,0.886610209941864
16,2018-06-07 02:32:00,"The Veeva Vault platform, for example, includes more than a dozen applications.",0.05167378857731819,0.006102234590798616,0.9422240257263184,neutral,0.04557155445218086
17,2018-06-07 02:32:00,"Currently, existing Veeva customers use an average 1.97 Veeva Vault products.",0.015652531757950783,0.007345182821154594,0.9770022630691528,neutral,0.008307348936796188
18,2018-06-07 02:32:00,"Veeva also continues to introduce new products, with the company's management team expressing significant enthusiasm in the Q1 earnings conference call for Nitro, a new commercial data warehouse for the life sciences industry.",0.9287194013595581,0.014255092479288578,0.0570254810154438,positive,0.9144642949104309
19,2018-06-07 02:32:00,"Third, there's a tremendous opportunity for Veeva to expand beyond its core life sciences market with its quality management software.",0.9028922915458679,0.01233919057995081,0.08476849645376205,positive,0.8905531167984009
20,2018-06-07 02:32:00,Veeva began moving into additional markets in 2016.,0.270073801279068,0.006294044200330973,0.7236322164535522,neutral,0.26377975940704346
21,2018-06-07 02:32:00,"The company now claims a growing list of nonhealthcare customers, including a large global consumer packaged goods company, three chemical companies that rank among the top 30 largest in the world, and a rapidly growing skincare company.",0.6124364137649536,0.010889772325754166,0.37667378783226013,positive,0.6015466451644897
22,2018-06-07 02:32:00,Veeva thinks that the total addressable market for its quality management products could exceed $1 billion annually.,0.3932364583015442,0.007950576022267342,0.598812997341156,neutral,0.385285884141922
23,2018-06-07 02:32:00,Much of this market is in highly regulated industries other than healthcare.,0.022347992286086082,0.005595773458480835,0.9720562100410461,neutral,0.016752218827605247
24,2018-06-07 02:32:00,Wall Street analysts project that Veeva will increase its earnings by an average annual rate of nearly 18% over the next five years.,0.9557543396949768,0.016847306862473488,0.02739839442074299,positive,0.9389070272445679
25,2018-06-07 02:32:00,"While that's well below the company's growth in previous years, it's still quite strong.",0.8175682425498962,0.020529361441731453,0.16190239787101746,positive,0.7970388531684875
26,2018-06-07 02:32:00,And that projection could underestimate Veeva's potential in gaining new customers in other industries.,0.6835533380508423,0.07652320712804794,0.23992353677749634,positive,0.6070301532745361
27,2018-06-07 02:32:00,"Athenahealth provides cloud-based software to healthcare providers, primarily physicians and hospitals.",0.026478111743927002,0.005358548369258642,0.9681633710861206,neutral,0.021119562909007072
28,2018-06-07 02:32:00,"The investing case for Athenahealth is similar in some ways to Veeva, but different in others.",0.07210098206996918,0.007143192924559116,0.9207558631896973,neutral,0.06495779007673264
29,2018-06-07 02:32:00,"Like Veeva, Athenahealth should enjoy strong earnings growth in the coming years.",0.9464927315711975,0.014585836790502071,0.03892144560813904,positive,0.9319068789482117
30,2018-06-07 02:32:00,"Wall Street expects even stronger earnings growth for Athenahealth, with a consensus estimate of nearly 24% annual earnings growth over the next five years.",0.9553712010383606,0.02108009345829487,0.02354876697063446,positive,0.9342911243438721
31,2018-06-07 02:32:00,The company anticipates continued momentum in its core market of providing solutions to physicians.,0.9318039417266846,0.013324200175702572,0.05487184599041939,positive,0.9184797406196594
32,2018-06-07 02:32:00,"However, Athenahealth should be able to achieve even more growth by providing additional solutions to hospitals, ancillary healthcare providers, employers, and payers.",0.8972151279449463,0.012433856725692749,0.09035098552703857,positive,0.8847812414169312
33,2018-06-07 02:32:00,Epic and Cerner together claim roughly 57% of the hospital market.,0.020120546221733093,0.006502178031951189,0.9733772277832031,neutral,0.013618368655443192
34,2018-06-07 02:32:00,Athenahealth thinks it can win over many of the hospitals at the lower end of the market that haven't implemented these larger systems.,0.905767560005188,0.01701895333826542,0.07721349596977234,positive,0.8887485861778259
35,2018-06-07 02:32:00,"Based on the company's track record, that seems like a good assumption.",0.1770687997341156,0.008437151089310646,0.8144940733909607,neutral,0.1686316430568695
36,2018-06-07 02:32:00,"In 2016, for example, Athenahealth won 46% of purchasing decisions made by stand-alone acute community hospitals.",0.7954123616218567,0.019048262387514114,0.18553930521011353,positive,0.7763640880584717
37,2018-06-07 02:32:00,But there's also another reason that investors might want to buy Athenahealth stock: The company itself is for sale.,0.05142616480588913,0.00696526886895299,0.9416085481643677,neutral,0.04446089640259743
38,2018-06-07 02:32:00,There had been speculation in recent months that Athenahealth could be on the block to be acquired.,0.07285667210817337,0.058838389813899994,0.8683049082756042,neutral,0.014018282294273376
39,2018-06-07 02:32:00,"However, one key potential impediment to a deal was the vision that CEO Jonathan Bush had for the company.",0.04801444336771965,0.5750061869621277,0.37697935104370117,negative,-0.5269917249679565
40,2018-06-07 02:32:00,That's not a factor anymore.,0.03984919190406799,0.049180351197719574,0.9109705090522766,neutral,-0.00933115929365158
41,2018-06-07 02:32:00,"On Wednesday, Athenahealth announced that Jonathan Bush was stepping down effective immediately.",0.04561977460980415,0.27817225456237793,0.676207959651947,neutral,-0.23255248367786407
42,2018-06-07 02:32:00,Bush faced allegations that he assaulted his then-wife 13 years ago and that he engaged in inappropriate office behavior.,0.0729917660355568,0.8715784549713135,0.05542971193790436,negative,-0.7985866665840149
43,2018-06-07 02:32:00,"With Bush's departure, Athenahealth's board of directors said that it had ""initiated a process to explore strategic alternatives.""",0.3589790463447571,0.013415995053946972,0.6276049613952637,neutral,0.34556305408477783
44,2018-06-07 02:32:00,These strategic alternatives include a sale or merger with another company.,0.04650677740573883,0.005754223093390465,0.9477389454841614,neutral,0.04075255244970322
45,2018-06-07 02:32:00,There's a possibility that a bidding war for Athenahealth could drive up its share price in the near term.,0.8954036831855774,0.03514212742447853,0.06945422291755676,positive,0.8602615594863892
46,2018-06-07 02:32:00,The stock is also more attractively valued than Veeva Systems right now.,0.8201830387115479,0.016463976353406906,0.16335298120975494,positive,0.8037190437316895
47,2018-06-07 02:32:00,Does that make Athenahealth the better buy?,0.2873350977897644,0.02800082415342331,0.6846640706062317,neutral,0.2593342661857605
48,2018-06-07 02:32:00,Not necessarily.,0.11418415606021881,0.09337984025478363,0.7924360036849976,neutral,0.02080431580543518
49,2018-06-07 02:32:00,I think Veeva has a slight edge over Athenahealth for one key reason: It doesn't have strong competition like Athenahealth does.,0.11263593286275864,0.07634080946445465,0.8110232353210449,neutral,0.036295123398303986
50,2018-06-07 02:32:00,"Also, there's a possibility that Athenahealth won't fetch as high of a price tag as some think it will.",0.07389283180236816,0.23018422722816467,0.6959229707717896,neutral,-0.1562913954257965
51,2018-06-07 02:32:00,"Finally, I prefer investing in stocks that I can own for the long run.",0.0848691388964653,0.005656133405864239,0.909474790096283,neutral,0.07921300828456879
52,2018-06-07 02:32:00,"That's an option with Veeva Systems, but it might not be with Athenahealth in light of recent developments.",0.022341344505548477,0.017008693888783455,0.9606499671936035,neutral,0.005332650616765022
53,2018-06-07 02:32:00,"10 stocks we like better than Veeva Systems

When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen.",0.12699975073337555,0.025114860385656357,0.8478853702545166,neutral,0.1018848866224289
54,2018-06-07 02:32:00,"After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor , has quadrupled the market.",0.8087436556816101,0.0373060368001461,0.15395022928714752,positive,0.7714376449584961
55,2018-06-07 02:32:00,"*

David and Tom just revealed what they believe are the 10 best stocks for investors to buy right now... and Veeva Systems wasn't one of them!",0.2355690747499466,0.014962825924158096,0.7494681477546692,neutral,0.2206062525510788
56,2018-06-07 02:32:00,That's right -- they think these 10 stocks are even better buys.,0.8146857619285583,0.02307075634598732,0.16224350035190582,positive,0.7916150093078613
57,2018-06-07 02:32:00,Click here to learn about these picks!,0.0694708302617073,0.055800698697566986,0.8747285008430481,neutral,0.01367013156414032
58,2018-06-07 02:32:00,Keith Speights has no position in any of the stocks mentioned.,0.009128669276833534,0.045183293521404266,0.9456880688667297,neutral,-0.03605462610721588
59,2018-06-07 02:32:00,The Motley Fool owns shares of and recommends Athenahealth and Veeva Systems.,0.0264567993581295,0.01115817204117775,0.9623850584030151,neutral,0.015298627316951752
60,2018-06-07 02:32:00,The Motley Fool recommends Cerner.,0.07089276611804962,0.0261527206748724,0.9029545187950134,neutral,0.044740043580532074
61,2018-06-07 02:32:00,The Motley Fool has a disclosure policy .,0.016547100618481636,0.017303917557001114,0.9661489725112915,neutral,-0.0007568169385194778
62,2018-06-07 02:32:00,"The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.",0.010204566642642021,0.01563790813088417,0.9741575717926025,neutral,-0.005433341488242149
